Department of Pharmacy Practice, Midwestern University, College of Pharmacy, Glendale Campus, 19555 N 59th Avenue, Glendale, AZ 85308, United States of America.
University of Arizona, College of Pharmacy, Department of Pharmacy Practice and Science, 1295 N Martin Ave, PO Box 210202, Tucson, AZ 85721, United States of America.
J Crit Care. 2022 Oct;71:154105. doi: 10.1016/j.jcrc.2022.154105. Epub 2022 Jun 29.
Obesity is highly prevalent in ICU patients presenting a number of challenges, one of which is drug dosing. There are limited high-quality data describing drug dosing in obesity, which can lead to dosing strategies that are suboptimal. For example, inappropriately using the wrong weight for weight-based dosing can lead to supratherapeutic drug concentrations and an adverse drug event or subtherapeutic drug concentrations and treatment failure. A generalized framework for decision making specific for obese patients is available that describes a step-by-step approach for constructing dosing regimens. This manuscript will build on that framework by providing pitfalls and pearls for clinicians to consider when making dosing decisions in critically ill patients with severe obesity.
肥胖症在 ICU 患者中极为普遍,给药物剂量调整带来了诸多挑战。目前仅有数量有限的高质量数据可用于描述肥胖症患者的药物剂量调整,这可能导致剂量调整策略并不理想。例如,在基于体重的药物剂量调整中使用错误的体重,可能导致药物浓度高于治疗范围,出现药物不良反应事件,或药物浓度低于治疗范围,导致治疗失败。目前已有专门针对肥胖患者的决策制定通用框架,该框架描述了为肥胖危重症患者构建给药方案的逐步方法。本文将在此框架基础上进一步阐述,为临床医生在为严重肥胖的危重症患者制定药物剂量调整决策时提供需要考虑的要点和注意事项。